0001127602-23-011750.txt : 20230403
0001127602-23-011750.hdr.sgml : 20230403
20230403101305
ACCESSION NUMBER: 0001127602-23-011750
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230330
FILED AS OF DATE: 20230403
DATE AS OF CHANGE: 20230403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kirchgraber Paul R
CENTRAL INDEX KEY: 0001791393
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11353
FILM NUMBER: 23791118
MAIL ADDRESS:
STREET 1: 531 SOUTH SPRING STREET
CITY: BURLINGTON
STATE: NC
ZIP: 27215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS
CENTRAL INDEX KEY: 0000920148
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 133757370
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
BUSINESS PHONE: 3362291127
MAIL ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19940314
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-03-30
0000920148
LABORATORY CORP OF AMERICA HOLDINGS
LH
0001791393
Kirchgraber Paul R
531 SOUTH SPRING STREET
BURLINGTON
NC
27215
1
CEO, Covance Drug Development
0
Common Stock
2023-03-30
4
A
0
6763
0
A
15832
D
Common Stock
2023-03-30
4
F
0
2886
224.70
D
12946
D
Shares acquired on March 30, 2023, pursuant to a performance award granted on February 4, 2020, relating to performance during the three-year period ended December 31, 2022.
Stock withholding to satisfy tax withholding obligations.
/s/ Sandra van der Vaart, Attorney-in-Fact for Paul R. Kirchgraber
2023-04-03